malondialdehyde has been researched along with Berger Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Li, S; Lin, Q; Ni, Z; Qi, C; Shao, X; Shen, J; Wu, J; Zhou, W; Zhu, X | 1 |
| Han, C; Jin, X; Tang, J; Zhang, L; Zhu, X | 1 |
| Ong-ajyooth, L; Ong-ajyooth, S; Parichatikanond, P | 1 |
| Chan, JC; Chan, W; Krieg, RJ; Norkus, EP | 1 |
| Horie, K; Inagi, R; Izuhara, Y; Kurokawa, K; Miyata, T; Sakai, H; Saotome, N; Suzuki, D; Uchida, K; Yagame, M; Yasuda, Y | 1 |
| Chan, JC; Chan, W; Krieg, RJ; Kuemmerle, NB; Norkus, EP; Trachtman, H | 1 |
| Hirano, H; Kodama, N; Mune, M; Otani, H; Yamada, Y; Yukawa, S | 1 |
1 trial(s) available for malondialdehyde and Berger Disease
| Article | Year |
|---|---|
Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
Topics: Adult; Biomarkers; Biopsy, Needle; Culture Techniques; Diabetic Nephropathies; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Glycation End Products, Advanced; Humans; Immunohistochemistry; Kidney Function Tests; Lysine; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Protein Denaturation; Reference Values; Sensitivity and Specificity | 1999 |
6 other study(ies) available for malondialdehyde and Berger Disease
| Article | Year |
|---|---|
Downregulation of PPARĪ± mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells.
Topics: Albumins; Creatinine; Down-Regulation; Fatty Acid-Binding Proteins; Ferroptosis; Glomerulonephritis, IGA; Glutathione; Humans; Immunoglobulin A; Malondialdehyde; Mesangial Cells; PPAR alpha; Reactive Oxygen Species; RNA, Small Interfering | 2022 |
Plasma gelsolin levels are decreased and correlate with fibrosis in IgA nephropathy.
Topics: Animals; Catalase; Disease Models, Animal; Disease Progression; Fibrosis; Gelsolin; Glomerulonephritis, IGA; Glutathione; Kidney; Malondialdehyde; Mice; Oxidative Stress; Superoxide Dismutase; Transforming Growth Factor beta1 | 2013 |
The effect of alpha-tocopherol on the oxidative stress and antioxidants in idiopathic IgA nephropathy.
Topics: alpha-Tocopherol; Antioxidants; Case-Control Studies; Female; Glomerulonephritis, IGA; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidative Stress; Prospective Studies; Time Factors | 2006 |
alpha-Tocopherol reduces proteinuria, oxidative stress, and expression of transforming growth factor beta 1 in IgA nephropathy in the rat.
Topics: Animals; Blotting, Northern; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Glomerulonephritis, IGA; Male; Malondialdehyde; Oxidative Stress; Proteinuria; Rats; Rats, Inbred Lew; RNA, Messenger; Transforming Growth Factor beta; Vitamin E; Weight Gain | 1998 |
Influence of alpha-tocopherol over the time course of experimental IgA nephropathy.
Topics: Animals; Blotting, Northern; Cattle; Diet; Glomerular Mesangium; Glomerulonephritis, IGA; Immunoglobulin A; Male; Malondialdehyde; Mycobacterium bovis; Oxidative Stress; Proteinuria; Rats; Rats, Inbred Lew; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Vitamin E | 1999 |
Evaluation of serum lipid abnormalities in chronic nephritis.
Topics: Adult; Age Factors; Apolipoproteins; Cholesterol; Cholesterol, HDL; Chronic Disease; Creatine; Female; Glomerulonephritis, IGA; Humans; Kidney; Lipids; Male; Malondialdehyde; Middle Aged; Phospholipids; Proteinuria; Triglycerides | 1999 |